CIPLA NEWS
India, Belarus hold first-ever consular dialogue in Minsk
India and Belarus conducted their inaugural Consular Dialogue in Minsk, addressing a wide range of consular issues including the welfare of Indian students in Belarus and boosting tourism between the two nations. The Indian delegation, led by Aman Puri, Joint Secretary (Consular, Passport and Visa Division), engaged with Belarusian counterparts headed by Andrei Kozhan, Head of General Directorate for Consular Affairs at Belarus' Ministry of Foreign Affairs.
Stocks in news: JSW Infra, Stanley Lifestyles, SAMHI Hotels, Bank Of Baroda, IREDA
Indicating that the company is still interested in the mega Tajpur deep sea port in West Bengal, JSW Infrastructure Ltd said that it remains open to re-evaluate its strategy for the project.
India to make drugs for diabetes, obesity under PLI by 2026, says report
India plans to incentivize local manufacturing of GLP-1 drugs, crucial for treating diabetes and obesity, starting in 2026, as per a government official speaking to Reuters. These drugs, originally approved for diabetes treatment, are also used for obesity due to their ability to slow digestion and reduce appetite. Novo Nordisk's patent on semaglutide, a key ingredient in popular drugs like Wegovy and Ozempic, is set to expire in India by 2026. Indian companies are already preparing to manufacture these drugs under the government's production-linked incentive (PLI) scheme.
Buy Cipla, target price Rs 1700: Motilal Oswal
Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 119417.66 Crore) operating in Pharmaceuticals sector.
Stocks in news: Adani Ports, Cipla, Prestige Estates, MCX, Lupin
Positive growth in domestic markets for the third consecutive week with a focus on Adani Ports, Cipla, Prestige Estates, MCX, Lupin. Updates on Thomas Cook India, SAIL, Wipro, Prestige Estates, Lupin, Cipla, MCX, TVS Motor, CSC Grameen eStores.
- Go To Page 1
Stocks in news: Paytm, Indus Towers, Vedanta, Cipla, Gland Pharma
Domestic markets start positively with Paytm, Indus Towers, Vedanta, Cipla, Gland Pharma in focus. ZEE appoints acting CFO. Tata Technologies partners with Microsoft. Wabco to sell ZF equity. Craftsman Automation launches QIP. Fosun Pharma reduces stake. Vedanta monetises steel business. Goldman Sachs sells One 97 shares; Vodafone sells Indus Towers shares; Generative AI hackathon.
Gland Pharma, Hindustan Copper among 18 stocks exited by 7 mutual funds in May
Around seven mutual funds exited from 18 stocks in their portfolio in May. Here is the breakdown of the stocks exited, according to Mutual Fund Insight by Nuvama Alternative & Quantitative Research.
3 top stock recommendations from Rajesh Palviya for next week
On the Bank Nifty, still Bank Nifty is struggling to give a decisive breakout above 50,000 mark, so that is the challenging level at this moment based on the call concentration.
Parag Parikh Flexi Cap Fund increases stake in ITC, HDFC and Kotak
Parag Parikh Flexi Cap Fund increases stake in ITC, HDFC, and Kotak while making exits from Bajaj Finance and HUL in May. The largest flexi cap fund manages assets worth Rs 66,383 crore and is benchmarked against Nifty 500- TRI.
Power Grid, Ramco Cements among 5 stocks with long buildup
A long buildup occurs when there is an increase in open interest and trading volumes alongside a rise in the price of the underlying stock in the Futures and Options segment, indicating a bullish trend in the market. In Monday's trading session, five stocks experienced a buildup of fresh long positions. Here's the list:
Top Nifty50 stocks analysts suggest buying this week
The latest Stock Reports Plus report dated June 2, 2024, highlighted Nifty50 stocks with 'Strong Buy/Buy' recommendations. The report evaluates key components of listed stocks to generate standardized scores for actionable insights.
Stock Radar: 50% rally in 1 year! Cipla breaks above a falling trendline resistance; should you buy?
After hitting a record high of Rs 1,519 on March 11, 2024, the pharma major lost steam. The recent stock action, however, suggests that the stock has bottomed out. It rose from Rs 916 as of May 19 to Rs 1,441 recorded on May 21. In May it made a double bottom pattern on the daily charts.
F&O stocks: Tata Consumer Products, Balkrishna Industries among 5 stocks with long buildup
The emergence of a bullish trend on specific stocks can be deduced by analyzing the open interest data. When a stock's price increases alongside a simultaneous rise in open interest, it suggests a buildup of fresh long positions.
SBI, Bank of Baroda among 5 stocks with long buildup
A long buildup occurs when there is an increase in open interest and trading volumes alongside a rise in the price of the underlying stock in the Futures and Options segment, indicating a bullish trend in the market. In Tuesday's trading session, five stocks experienced a buildup of fresh long positions. Here's the list:
Top Nifty50 stocks analysts suggest buying this week
Stock Reports Plus report on May 19, 2024 features 'Strong Buy/Buy' recommendations for Nifty50 stocks using IBES. It evaluates earnings surprises, estimate revisions, and 5 key components via Refinitiv.
F&O stocks: Hindustan Aeronautics, Mphasis among 5 stocks with short buildup
In Friday's trading session, the following five stocks witnessed a build of fresh short positions. Let us first understand how this conclusion is reached that whether the stock has seen a buildup of fresh short position or not. To understand it we have to look at what “short selling” means.
Sensex, Nifty edge lower as HDFC Bank drags; US inflation data looms
IT stocks presented a muted show as investors turn cautious ahead of key US data that will determine future interest rate trends. Sensex dipped 118 points to settle at 72,987. Nifty shed 17 points to end at 22,200.
Cipla promoters sell 2.53% stake for around Rs 2,600 crore
Promoters of Cipla, including Person Acting in Concert, sold 2.04 crore shares in a block deal worth around Rs 2,600 crore to create liquidity for specific needs, including philanthropy. After the stake sale, the entire promoter group holds 31.67% in Cipla, expressing commitment to the company's future.
Stocks in news: PFC, Mankind Pharma, Patanjali Foods, Bharti Airtel, Siemens, Cipla
Benchmark equities surged for the third consecutive day on Tuesday. PFC, Mankind Pharma, Patanjali Foods, Bharti Airtel, Siemens, and Cipla are in focus for news developments and quarterly results. RVNL, Dixon, and Titagarh will also announce their fourth quarter results today.
Promoter group entities likely to sell 2.5% stake in Cipla worth Rs 2,637 crore via block deals: Report
The price range of the block is fixed at Rs 1,289-1,357, taking the total deal value to around Rs 2,637 crore.
Adani Ports, Cipla among 5 stocks with short buildup
A short buildup is when there is a rise in open interest and volumes along with a decrease in the price of the underlying stock in the Futures and Options segment. Short buildup means more people are expecting the prices to go down and creating short positions. In Tuesday’s trading session, five stocks witnessed a build of fresh short positions. Here's the list:
F&O stocks: Asian Paints, Cipla among 5 stocks with long buildup
Some additional checks would help traders in taking better trading decisions as they increase the probability of a follow-up of the upward movement in the stock price. First, if this fresh long build has come when the stock isvery close to its 52-week high, that increases the probability of the stock making an attempt to break its previous 52-week high.
Cipla shares surge over 6% post Q4 results. Should you buy or sell?
Meanwhile, EBITDA for the quarter under review increased 13% YoY to Rs 1,316 crore as against 1166 crore in the last year period.
Cipla Q4 Results: Profit soars 79% YoY to Rs 939 crore; dividend declared at Rs 13 per share
Cipla Q4 Results: Revenue from operations increased 7% year-on-year to Rs 6,163 crore in the March quarter. EBITDA for the quarter under review increased 13% year-on-year to Rs 1,316 crore as against 1166 crore in the last year period.
Stocks in news: Tata Motors, Bank of Baroda, Cipla, BPCL, Manappuram Finance
State-run BPCL on Thursday posted a 35% drop in its standalone net profit at Rs 4,224 crore in the fourth quarter, compared with Rs 6,478 crore in the last year period.
Stocks in news: RIL, Jio Financial, JSW Infra, Cipla, Gujarat Gas
Reliance Industries Ltd will announce its March quarter results on April 22. Along with the quarterly numbers, the company's board will also consider and approve a dividend.
Load More
